Treatment



Disclaimer

 

Medifix has taken all reasonable care to ensure that pages published in our website were accurate on the stated date of publication or last modification. Other pages which may be linked to our home page or to other pages, or which have a address, may have been published by others. Medifix takes no responsibility for the consequences of error or for any loss or damage suffered by users of any of the information published on any of these pages, and such information does not form any basis of a contract with readers or users of it.

 

It is in the nature of Web sites, many of which are experimental or constantly changing, that information published may be for test purposes only, may be out of date, or may be the personal opinion of the author. Readers should verify information gained from the Web with the appropriate authorities before relying on it.

If you think you are very ill, please consult your doctors.

 

(PS: I am still updating this information, your contributions help, so please email me a note)

Information in this page will be linked to the authors.

 

My apology if I have missed any links to websites and articles, please emalil me a note: Medifix

Top


Genetic Mutations and Molecular Information - Genetic Entropy

 

 

This video is excerpted from the AiG Answers In Genesis DVD called The Code of Life by Dr. Georgia Purdom. This DVD explores the fascinating world of DNA and clearly show that junk DNA isn't junk and that mutations and natural selection are headed in the wrong direction, corrupting and decreasing information in DNA making evolution impossible. Evolutionist require significant change in any given DNA sequence over long periods of time, yet this required drift is not what science has found.

There are many ancient bacterium fossils recovered and revived from salt crystals and amber crystals that have been compared to their living descendants of today. Some bacterium spores, in salt crystals, dating back as far as 250 million years have been revived, had their DNA sequenced, and compared to their offspring of today Vreeland RH, 2000 Nature.

Scientists accomplished this using a technique called polymerase chain reaction PCR. To the disbelieving shock of many scientists, both ancient and modern bacteria were found to have the almost exact DNA sequence. Almost without exception, bacteria isolated from ancient material have proven to closely resemble modern bacteria at both morphological and molecular levels. Heather Maughan, C. William Birky Jr., Wayne L. Nicholson, William D. Rosenzweig and Russell H. Vreeland The Paradox of the Ancient Bacterium Which Contains Modern Protein-Coding Genes

How to manage MRSA skin infections.

In early September, NEJM presented a case of a college athlete with a skin and soft-tissue infection in Clinical Decisions, an interactive feature designed to assess how readers would manage a clinical problem for which there may be more than one appropriate treatment. The result of their survey is now published.

New Antibiotic

Aminomethylcyclines (AMCs)

AMCs were evolved from tetracycline antibiotics as potential agents to combat multiple antibiotic-resistant bacteria, including MRSA, penicillin-resistant Streptococcus pneumoniae (PRSP), vancomycin-resistant Enterococcus (VRE), multidrug resistant Escherichia coli and other difficult-to-treat pathogens. Introduced more than 50 years ago, tetracyclines remain among the most commonly used antiinfective agents to combat bacterial infections. However, the emergence of resistance has curtailed their effectiveness in certain infections. Paratek has utilized its expertise to create AMC compounds, such as PTK 0796, that retain the appealing safety and spectrum of activity of the tetracyclines while overcoming tetracycline and multi-drug resistance.

Linezolid (Zyvox)

New Antibiotic was approved by the Food and Drug Administration (FDA) in 2000 to treat a variety of infections, including some caused by bacteria resistant to the drug methicillin. Methicillin – resistant Staphylococcus aureus (MRSA) has become a major cause of infections both in hospitals and communities. For years the antibiotic vancomycin had been a last line of defence against infections caused by MRSA and other antibiotic-resistant “super bugs,” but now vancomycin-resistant infections have been reported.

Linezolid is among the first new treatments for MRSA infections since vancomycin was introduced in the 1950s. Unlike other newer antibiotics for MRSA and VRE, linezolid can be given orally, as well as intravenously, making it suitable for outpatient use.

Linezolid produced a clinical cure for 81 percent of patients, while the comparator combination was effective for 71 percent of patients. Statistically, the overall results for the two groups were about equal. However, linezolid outperformed the aminopenicillin treatments in the largest subgroup: patients with an infected ulcer, as opposed to cellulites, osteomyelitis, or other less common types of diabetic foot infections.

First report of Linezolid Resistant SA Emerging (LRSA):

Ceftobiprole

Ceftobiprole has been granted "fast-track" status from the FDA and is licensed from, and is being co-developed with, Basilea Pharmaceutica Ltd, Switzerland, through an exclusive worldwide collaboration.

New drug, called Ceftobiprole, was tested against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.

By targeting the gene that confers such resistance, a new drug may be able to finally fight them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria. Ceftobiprole worked against bacterial clones that had already developed resistance to other drugs. Previous research had already shown that — in general — Ceftobiprole was highly effective against most clinical isolates of S. aureus.

In the past newer antibiotic arrives on the scene, and sooner or later resistant bacteria emerge.

In patients with complicated skin infections, outcomes were similar for ceftobiprole (a broad-spectrum cephalosporin with activity against MRSA) and vancomycin

Dalbavancin

Pfizer announced today that it would withdraw marketing application being considered at FDA and the European Medicines Agency (EMEA) for Dalbavancin an antibiotic it was developing for complicated skin infections caused by bacteria including methicillin-resistant Staphylococcus aureus (MRSA).

Chemicals in Marijuana May Fight MRSA

Study Shows Cannabinoids May Be Useful Against Drug-Resistant Staph Infection

Researchers in Italy and the U.K. tested five major marijuana chemicals called cannabinoids on different strains of MRSA (methicillin-resistant Staphylococcus aureus). All five showed germ-killing activity against the MRSA strains in lab tests. Some synthetic cannabinoids also showed germ-killing capability. The scientists note the cannabinoids kill bacteria in a different way than traditional antibiotics, meaning they might be able to bypass bacterial resistance. Ref: G. Journal of Natural Products, 2008; vol 71: pp 1427-1430

Manuka Honey

Researchers have examined MRSA that has come in contact with Manuka Honey and have determined that MRSA cannot survive in the healing environment created by Manuka Honey. MRSA is a bacterium that grows and divides into two similar cells every half hour. It divides by forming a wall across the middle of the cell, which then splits in half to create two new cells. Studies have shown that Manuka Honey interferes with the cell cycle of MRSA by affecting the separation of new cells, so that cells unable to complete division are disabled at that point in the cell cycle.

All types of honey contain hydrogen peroxide which is a known antiseptic and disinfectant. Manuka honey has an additional antibacterial component making it much more effective for therapeutic use. This additional component, known as UMF, is unaffected by enzymes that dilutes the effectiveness of regular honey. It remains active when used as a wound dressing and diffuses deeper into skin tissues.

Manuka Honey is also considered to be antimicrobial and, therefore, capable of treating local bacterial and fungal skin infections. We are a long way from using this as a cure or using the knowledge to develop new antibiotics.

Teatre OIL (Melaleuca Alternifolia)

This essential oil fumes is said to reduce colony count in the hospitals and office but not on skin and for wounds. Various companies are marketing products made from this oil as antiseptic, acne treatment, after shave lotions and even for thrush and other fungal infections. They are can damage skin and mucus membrane which will later get colonized with bacteria.

Bacteriophage

 

Use of Bacteriophage for local and intestinal infections is still controversial but there is no treatment available for treating bloodstream infection. Some microbiologist think MRSA will be more virulent when they are infected with a bacteriophage. Bacteriphage can carry plasmid from one bacteria to another.

MRSA and other super bugs have made many people anxious, and they are looking for ways to avoid these germs.  But everyone needs to know that antibacterial products are NOT the best line of attack against  MRSA and other germs.  While they can help in a pinch, overuse is linked to antibiotic-resistance

The Ganges is a place of death and life. Hindus from all over will bring their dead. Whether a body or just ashes, the waters of the Ganga are needed to reach Pitriloka (the World of the Ancestors). Just as in the myth with King Sargas' 60,000 sons who attained heaven by Ganga pouring down her water upon their ashes, so the same waters of Ganga are needed for the dead in the Hindu belief today. Without this, the dead will exist only in a limbo of suffering, and would be troublesome spirits to those still living on earth. The waters of the Ganges are called amrita, the "nectar of immortality".

Are viruses (Bacteriophage) the answer to fight this "Super Bacteria"?

Use of Bacteriophage for local and intestinal infections is still controversial but there is no treatment available for treating bloodstream infection. Some microbiologist think MRSA will be more virulent when they are infected with a bacteriophage. Bacteriphage can carry plasmid from one bacteria to another.

MRSA and other super bugs have made many people anxious, and they are looking for ways to avoid these germs.  But everyone needs to know that antibacterial products are NOT the best line of attack against  MRSA and other germs.  While they can help in a pinch, overuse is linked to antibiotic-resistance

ATEL Ventures Invests $1.8 Million of Financing in GangaGen, Inc.

Innovative approach revolutionize the treatment of antibiotic resistant bacterial infections such as Methicillin-resistant Staphylococcus aureus (MRSA) using bacteriophage....

Drug choice is not the biggest challenge of MRSA treatment and cell wall synthesis, however, is not the only common target of antibiotics. The cell wall becomes susceptible to the autolytic enzymes that degrade the cell wall and becomes permeable to the environment, leading to bacterial lysis.

Improving infection control would prevent the spread of resistant strains as rapid methods of Triathlon poster pathogens would lead to faster isolation of colonized patients, making it harder for disease to spread. Antibiotic Treatment of Adults With Sore Throat by Community Primary Care Physicians A National Survey.

Scientists may soon shed light on a way to conquer “superbugs” with nanotechnology and a simple flip of a switch. A new type of paint for walls and ceilings may, when exposed to fluorescent light, be able to kill “superbugs,” antibiotic-resistant bacteria, according to preliminary studies led by Lucia Caballero from Manchester Metropolitan University in England

Allicin and methicillin-resistant Staphylococcus aureus

The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and the community has led to a demand for new agents that could be used to decrease the spread of these bacteria. Topical agents such as mupirocin have been used to reduce nasal carriage and spread and to treat skin infections; however, resistance to mupirocin in MRSAs is increasing. Allicin is the main antibacterial agent isolated from garlic, but natural extracts can be unstable. In this study, a new, stable, aqueous extract of allicin (extracted from garlic) is tested on 30 clinical isolates of MRSA that show a range of susceptibilities to mupirocin.

 



 

 

 

 

Registration Form

Effect of teatre oil on lip


©2008 Medifix & Samsarx ®